Summary
In type 1 diabetes, alpha and beta cells both become dysfunctional, but beta cells die. Alpha cells express more antiapoptotic BCL2L1, protective BiP, antiviral genes, and immune-inhibitory HLA-E. Beta cells show more proapoptotic CHOP, while invading CD8 T cells recognize preproinsulin rather than glucagon, concentrating immunogenic stress on beta cells.
By Intermission· 903 words
Why do pancreatic beta cells fail?
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes? | Nature Reviews Endocrinology
[1]Summary
In type 1 diabetes, alpha and beta cells both become dysfunctional, but beta cells die. Alpha cells express more antiapoptotic BCL2L1, protective BiP, antiviral genes, and immune-inhibitory HLA-E. Beta cells show more proapoptotic CHOP, while invading CD8 T cells recognize preproinsulin rather than glucagon, concentrating immunogenic stress on beta cells.
Bearing
It answers the selectivity problem through unequal resilience and antigenicity, not a beta-cell-only immune mechanism. Lower antiapoptotic, chaperone, antiviral, and HLA-E defenses leave beta cells less able to survive ER or viral stress. Preproinsulin-specific T-cell recognition then adds targeted pressure. The preview supports this synthesis at abstract level.
The immunology of type 1 diabetes | Nature Reviews Immunology
[2]Summary
This review surveys type 1 diabetes immune mechanisms, emphasizing T cells and autoimmune beta-cell destruction. It connects T-cell-directed treatment with delayed disease progression and calls for better immunobiology and monitoring of residual beta-cell mass and function. The available preview supports these broad conclusions, not detailed cellular mechanisms.
The role of the beta cell in type 2 diabetes: new findings from the last 5 years | Diabetologia | Springer Nature Link
[3]Summary
This human-focused review places beta-cell dysfunction at the centre of type 2 diabetes. Early insulin-secretory abnormalities can precede reduced beta-cell mass. Risk variants, intra-islet and inter-organ signals, heterogeneity, and sex-related responses shape vulnerability. Clinical evidence shows weight loss and incretin-based therapies can restore function and produce remission.
Checking your browser - reCAPTCHA
[4]Summary
This frozen page contains a browser-verification challenge rather than article text. It identifies no beta-cell findings, study methods, results, or references. Consequently, it provides no substantive evidence about pancreatic beta-cell failure.
From human to mouse and back: genetic and genomic ta(i)les of islet dysfunction in type 2 diabetes - PMC
[5]Summary
This review frames type 2 diabetes beta-cell failure as genetically patterned islet dysfunction interacting with environment. Human and mouse genomics connect risk variants to insulin synthesis, proinsulin processing, secretion, mitochondrial maintenance, stress responses, and apoptosis. Multi-omic and context-specific analyses reveal heterogeneous pathways, while model differences limit direct translation.
The role of the beta cell in type 2 diabetes: new findings from the last 5 years - PMC
[6]Summary
In type 2 diabetes, early beta-cell dysfunction and inadequate insulin secretion drive hyperglycaemia before beta-cell mass loss. Genetic variants affect development, secretion, and stress resilience. Signals from islets, exocrine pancreas, gut, and insulin-sensitive tissues compound defects, while heterogeneous stress responses help explain progression and remission after weight loss or incretin treatment.
The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events? - PMC
[7]Summary
Type 1 diabetes beta-cell failure reflects reciprocal T-cell and beta-cell activity. High insulin-production demands create ER and oxidative stress, while inflammatory mediators and beta-cell antigen release can intensify autoimmunity. Beta cells may initiate, amplify, and finally complete their destruction through intrinsic stress and death, although protective responses can delay progression.
Βeta-Cells: Stress, Identity, Failure and Diabetes - PMC
[8]Summary
This review describes type 2 diabetes beta-cell failure as a shift from compensation to chronic stress. Glucotoxicity, lipotoxicity, ER and mitochondrial dysfunction, inflammation, senescence, and altered islet interactions reduce insulin production and secretion. Loss of beta-cell identity and heterogeneous stress responses help determine whether cells adapt, dedifferentiate, or die.
Sources
Comments